Skip to main content
SpringerLink
Log in
Book cover

Therapieresistente Depressionen pp 101–109Cite as

Antidepressiva-Kombinationen bei therapieresistenten Depressionen

  • Conference paper

  • 75 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Apter JT, Kushner SF, Woolfolk RL (1994) Bupropion/Nortriptyline combination for refractory depression. Ann Clin Psychiatry 6: 255–258

    Google Scholar 

  • Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248–251

    Google Scholar 

  • Bakish D (1994) Potentiation of fluoxetine by buspirone and trazodone in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. Wiley, New York, pp. 143–145

    Google Scholar 

  • Bauer M, Linden M (1993) Die Kombination verschiedener Antidepressiva in der Behandlung therapieresistenter Depressionen. Nervenarzt 64: 343-347

    Google Scholar 

  • Berlanga C, Ortega-Soto HA (1995) A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination. J Affect Disorders 34: 187–192

    Google Scholar 

  • Blecourt CV de, Gudde H (1992) Surplus value of combining antidepressants in refractory depression. Second International Conference on Refractory Depression, 24. - 26.6.1992, Amsterdam (Abstract)

    Google Scholar 

  • Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217–222

    Google Scholar 

  • Boyer WF, Feighner JP (1991) Pharmacokinetics and drug interactions. In: Feighner JP, Boyer WF (eds) Selective serotonin re-uptake inhibitors. Wiley, New York, pp. 81–58

    Google Scholar 

  • Ebert D, Albert R, May A, Stosiek I, Kaschka W (1995) Combined SSRI–RIMA treatment in refractory depression–safety data and efficacy. Psychopharmacology 119: 342–344

    Google Scholar 

  • Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A douple-blind, controlled study. Am J Psychiatry 151: 1372-1374

    Google Scholar 

  • Feighner JP, Boyer WF, Tyler DL, Neborsky R (199o) Adverse consequences of fluoxetineMAOI combination therapy. J Clin Psychiatry 51: 222–225

    Google Scholar 

  • Heimchen H (199o) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (ed) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin, Heidelberg, S. 237–250

    Google Scholar 

  • Jacobsen FM (1990) Low-dose trazodone as a hypnotic in patients treated with MAOI and other psychotropics: A pilot study. J Clin Psychiatry 51: 298–302

    PubMed  CAS  Google Scholar 

  • Jacobsen FM (1991) Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry 52: 217–220

    PubMed  CAS  Google Scholar 

  • Joffe RT, Bakisch D (1994) Combined SSRI-moclobemide treatment of psychiatric illness. J Clin Psychiatry 55: 24–25

    PubMed  CAS  Google Scholar 

  • Joffe RT, Schuller DR (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 54: 269–271

    Google Scholar 

  • Kuhs H (1995) Stufen in der Behandlungsresistenz bei depressiven Störungen, definiert nach somatotherapeutischen Verfahren. Nervenarzt 66: 561–567

    PubMed  CAS  Google Scholar 

  • Lauritzen L Clemmensen L, Klysner R, Loldrup D, Lunde M, Schaumburg E, Waarst S, Bech P (1992) Combined treatment with imipramine and mianserine: A controlled pilot study. Pharmacopsychiatry 25: 182–186

    Google Scholar 

  • Linden M, Helmchen H, Mackert A, Müller-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients. Pharmacopsychiatry 27(Suppl.): 51–53

    Google Scholar 

  • Möller HJ (1991) Therapieresistenz auf Antidepressiva: Risikofaktoren and Behandlungsmöglichkeiten. Nervenarzt 62: 658–669

    PubMed  Google Scholar 

  • Nelson JC (1993) Combined treatment strategies in Psychiatry. J Clin Psychiatry 54: 42–49

    Google Scholar 

  • Nelson JC, Mazure CM, Bowers MB, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48: 303–307

    Article  PubMed  CAS  Google Scholar 

  • Nierenberg M (1994) The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 55(9): 55–59

    Google Scholar 

  • Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M (1994) Trazodone for antidepressant-associated insomnia. Am J Psychiatry 151: 1069–1072

    Google Scholar 

  • Nierenberg AA, Cole JO, Glass L (1992) Possible trazodone potentiation of fluoxetine: A cases series. J Clin Psychiatry 53: 83–85

    Google Scholar 

  • Nierenberg M, Keck PE (1989) Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol 9: 42–45

    Google Scholar 

  • O’Brien S, McKeon P, O’Regan M (1993) The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups. Br J Psychiatry 162: 363–368

    Google Scholar 

  • Rosenthal JS, Kaswan MJ, Hemlock C, Winston A (1991) Fluoxetine enhancement of heterocyclic antidepressants. In: Amsterdam JD (ed) Refractory depression. Raven, New York, pp. 105–108

    Google Scholar 

  • Saria A, Neumann R, Humpel C, Lieder F, Dosser G, Oberbauer H (1991) Plasma levels of amitriptyline during treatment of depression: Influence of combined treatment with dibenzepine. In: Racagni G, Brunello N, Fukuda T (eds) Biological Psychiatry, Volume 1, Elsevier, Amsterdam, pp. 365–367

    Google Scholar 

  • Schmauss M, Kampfhammer HP, Meyr P, Hoff P (1986) Combined MAO-inhibitor and tri-(tetra-) cyclic antidepressant treatment in therapy resistant depression: A retrospective study. Pharmacopsychiatry 19: 251–252

    Google Scholar 

  • Seth R, Jennings AL, Bindman J, Philips J, Bergmann K (1992) Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161: 562–565

    Article  PubMed  CAS  Google Scholar 

  • Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705–713

    PubMed  CAS  Google Scholar 

  • Tanum LH (1994) Combination treatment with antidepressants in refractory depression. Int Clin Psychopharmacology 9: 37–40

    Google Scholar 

  • Taylor D (1995) Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination: Interactions and therapeutic uses. Br J Psychiatry 167: 575-580

    Google Scholar 

  • Wailnöfer A, Guentert TW, Eckernäs SA, Dingemanse J (1995) Moclobemide and fluvoxamine co-administration: A prospective study in healthy volunteers to investigate the potential development of the „serotonin syndrome“. Human Psychopharmacol 1o: 25–31

    Google Scholar 

  • Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: A preliminary report. J Clin Psychiatry 50: 447–449

    Google Scholar 

  • White K, Pistole T, Boyd JL (1980) Combined monamine oxidase inhibitor-tricyclic antidepressant treatment: A pilot study. Am J Psychiatry 137: 1422–1425

    Google Scholar 

  • White K, Simpson G (1986) Combined MAOI-tricyclic antidepressant treatment: A reevaluation. J Clin Psychopharmacol 1: 264–282

    Google Scholar 

  • Zajecka JM, Jeffries H, Fawcett J (1995) The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: A retrospective analysis. J Clin Psychiatry 56: 338–343

    Google Scholar 

  • Zimmer B, Daly F, Benjamin L (1984) More on combination antidepressant therapy. Arch Gen Psychiatry 41: 527–528

    Article  PubMed  CAS  Google Scholar 

  • Zimmer R, Gieschke R, Fischbach R, Gasic S (1990) Interaction studies with moclobemide. Acta Psychiatr Scand 360: 84–86

    Article  CAS  Google Scholar 

Download references

Authors
  1. P. Mavrogiorgou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Juckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Hellweg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Freien Universität Berlin, Eschenallee 3, 14050, Berlin, Deutschland

    Michael Bauer  & Anne Berghöfer (Ärztin) &  (Ärztin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Mavrogiorgou, P., Juckel, G., Hellweg, R. (1997). Antidepressiva-Kombinationen bei therapieresistenten Depressionen. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10500-9_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61675-7

  • Online ISBN: 978-3-662-10500-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation